Thalmann G - Search Results

1

Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial.

Attard G, Sydes MR, Mason MD, Clarke NW, Aebersold D, de Bono JS, Dearnaley DP, Parker CC, Ritchie AW, Russell JM, Thalmann G, Cassoly E, Millman R, Matheson D, Schiavone F, Spears MR, Parmar MK, James ND. Attard G, et al. Among authors: thalmann g. Eur Urol. 2014 Nov;66(5):799-802. doi: 10.1016/j.eururo.2014.05.038. Epub 2014 Jun 27. Eur Urol. 2014. PMID: 24985962 Free article. Clinical Trial.

2

Radical prostatectomy or wait-and-watch?

Studer UE, Thalmann G, Zingg EJ. Studer UE, et al. Among authors: thalmann g. Eur Urol. 1993;24 Suppl 2:24-8. doi: 10.1159/000474384. Eur Urol. 1993. PMID: 8262120

3

Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.

Thalmann GN, Sermier A, Rentsch C, Möhrle K, Cecchini MG, Studer UE. Thalmann GN, et al. J Urol. 2000 Dec;164(6):2129-33. J Urol. 2000. PMID: 11061941

4

Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer.

Aebersold DM, Isaak B, Thalmann G, Behrensmeier F, Kolotas C, Kranzbühler H, Mini R, Greiner RH. Aebersold DM, et al. Among authors: thalmann g. Strahlenther Onkol. 2004 Jun;180(6):351-7. doi: 10.1007/s00066-004-1225-2. Strahlenther Onkol. 2004. PMID: 15175869 Clinical Trial.

5

Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?

Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE. Schumacher MC, et al. Eur Urol. 2006 Aug;50(2):272-9. doi: 10.1016/j.eururo.2006.01.061. Epub 2006 Feb 28. Eur Urol. 2006. PMID: 16632187

6

Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.

Peternac D, Klima I, Cecchini MG, Studer UE, Thalmann GN. Peternac D, et al. Among authors: thalmann gn. J Urol. 2006 Jul;176(1):354-60. doi: 10.1016/S0022-5347(06)00516-7. J Urol. 2006. PMID: 16753443

7

Words of wisdom. Re: Detection of occult lymph node metastases in locally advanced node-negative prostate cancer.

Thalmann GN. Thalmann GN. Eur Urol. 2007 Aug;52(2):608-9. doi: 10.1016/j.eururo.2007.04.094. Eur Urol. 2007. PMID: 17674444 No abstract available.

8

The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

Mattei A, Fuechsel FG, Bhatta Dhar N, Warncke SH, Thalmann GN, Krause T, Studer UE. Mattei A, et al. Among authors: thalmann gn. Eur Urol. 2008 Jan;53(1):118-25. doi: 10.1016/j.eururo.2007.07.035. Epub 2007 Aug 3. Eur Urol. 2008. PMID: 17709171

9

Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution?

Kessler TM, Ochsner K, Studer UE, Thalmann GN. Kessler TM, et al. Eur Urol. 2008 May;53(5):1040-6. doi: 10.1016/j.eururo.2007.09.044. Epub 2007 Oct 8. Eur Urol. 2008. PMID: 17935875

10

Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.

Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE. Westermann DH, et al. J Urol. 2008 Jan;179(1):163-6. doi: 10.1016/j.juro.2007.08.172. Epub 2007 Nov 14. J Urol. 2008. PMID: 18001800 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page